Contact Us
Drug Search Results
More Filters [+]

Cromoglicic acid

Alternative Names: cromoglicic acid, cromolyn, nalcrom, cromolyn sodium, natriumcromoglicat, cromoglicato, gastrocrom, nasalcrom, intal, cromoptic, crolom, opticrom
Latest Update: 2024-11-18
Latest Update Note: Clinical Trial Update

Product Description

Cromoglicic acid (cromolyn) is regarded as a mast cell stabilising drug, although its exact mechanism of action appears to be much more complicated. Recent reports suggest that cromolyn inhibits glycogen synthase kinase 3beta and may therefore have potential to treat diabetes and obesity [2] and may prove effective in treating insulin-induced lipoatrophy (Sourced from: https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7608)

Mechanisms of Action: Mast Cell Stabilizer,GSK3B Inhibitor

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral,Nasal

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Argentina | Australia | Austria | Belgium | Bosnia | Brazil | Bulgaria | Canada | Chile | Colombia | Czech | Denmark | Dominican Republic | Egypt | Estonia | Finland | France | Germany | Greece | Hungary | Iceland | India | Ireland | Israel | Italy | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malta | Mexico | Netherlands | New Zealand | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Singapore | Slovakia | Slovenia | Spain | Sweden | Switzerland | Taiwan | Turkey | Ukraine | United Kingdom | United States | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Cromoglicic acid

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title

05/29/2024

News Article

 Norwell Consumer Healthcare introduces new women's health brand in Canada with the launch of Weliva™ Cimidona® for natural, clinically proven relief of menopausal symptoms

09/26/2023

News Article

 Contact Lenses for Astigmatism Market 2023 Size, Share, Growth, Report 2031

09/25/2023

News Article

 Digital Signage Screens Market Size, Forecast, Report 2023-2031

09/25/2023

News Article

 Steroid-Free Nasal Sprays Market Growth, Business Strategies, Demand, Emerging Trends and Forecast 2023-2030

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions